Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R de Wit

Showing results (21-30 of 147) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 26, 2001
A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancerJ Bellmunt, R de Wit, J Albanell, et al.
Oncology|June 1, 1996
Optimal control of acute cisplatin-induced emesisJ Verweij, R de Wit, P H de Mulder
British Journal of Cancer|December 18, 2008
Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancerW M van Weerden, C Bangma, R de Wit
American Journal of Clinical Oncology|April 1, 1993
Piritrexim-induced pulmonary toxicityR de Wit, J Verweij, R Slingerland, et al.
World Journal of Urology|October 8, 2005
Evaluation of early pelvic floor physiotherapy on the duration and degree of urinary incontinence after radical retropubic prostatectomy in a non-teaching hospitalE B Cornel, R de Wit, J A Witjes
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Chemotherapy in metastasized breast carcinoma]M Bontenbal, R de Wit, J G Klijn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2008
When to start cytotoxic therapy in asymptomatic patients with hormone refractory prostate cancer?P Hamberg, P C M S Verhagen, R de Wit
Environmental Microbiology|April 16, 2013
Linking the lytic and lysogenic bacteriophage cycles to environmental conditions, host physiology and their variability in coastal lagoonsC F Maurice, C Bouvier, R de Wit, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Possible lack of full cross-resistance of 5HT3 antagonists; a pilot studyM de Boer, R de Wit, G Stoter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2021
Outcomes of treatment choices in poor prognosis prostate cancer: not against all oddsD G J Robbrecht, S A J Buck, R de Wit
Pageof 15

Showing results (21-30 of 147) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|October 26, 2001
A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancerJ Bellmunt, R de Wit, J Albanell, et al.
Oncology|June 1, 1996
Optimal control of acute cisplatin-induced emesisJ Verweij, R de Wit, P H de Mulder
British Journal of Cancer|December 18, 2008
Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancerW M van Weerden, C Bangma, R de Wit
American Journal of Clinical Oncology|April 1, 1993
Piritrexim-induced pulmonary toxicityR de Wit, J Verweij, R Slingerland, et al.
World Journal of Urology|October 8, 2005
Evaluation of early pelvic floor physiotherapy on the duration and degree of urinary incontinence after radical retropubic prostatectomy in a non-teaching hospitalE B Cornel, R de Wit, J A Witjes
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Chemotherapy in metastasized breast carcinoma]M Bontenbal, R de Wit, J G Klijn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2008
When to start cytotoxic therapy in asymptomatic patients with hormone refractory prostate cancer?P Hamberg, P C M S Verhagen, R de Wit
Environmental Microbiology|April 16, 2013
Linking the lytic and lysogenic bacteriophage cycles to environmental conditions, host physiology and their variability in coastal lagoonsC F Maurice, C Bouvier, R de Wit, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Possible lack of full cross-resistance of 5HT3 antagonists; a pilot studyM de Boer, R de Wit, G Stoter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2021
Outcomes of treatment choices in poor prognosis prostate cancer: not against all oddsD G J Robbrecht, S A J Buck, R de Wit
Pageof 15